These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3953428)

  • 41. The antihypertensive effect of verapamil on twice and thrice daily dose regimens. A randomized, double-blind, crossover trial.
    Hedbäck B; Parment K
    J Int Med Res; 1983; 11(3):190-3. PubMed ID: 6347752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.
    Ferrier C; Ferrari P; Weidmann P; Keller U; Beretta-Piccoli C; Riesen WF
    Drugs; 1992; 44 Suppl 1():74-84. PubMed ID: 1283588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the efficacy and tolerability of lisinopril and sustained-release verapamil in older patients with hypertension.
    Weir MR; Lavin PT
    Clin Ther; 1991; 13(3):401-8. PubMed ID: 1659494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Casual versus 24-hour ambulatory blood pressure recording in the evaluation of chronic administration of sustained-release verapamil.
    Cardillo C; Savi L; Musumeci V; Mores N; Mettimano M; Costalunga A; Guerrera G; Melina D; Folli G
    J Hum Hypertens; 1988 Mar; 1(4):281-5. PubMed ID: 3221375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.
    García de Vinuesa S; Luño J; Gómez-Campderá F; Ridao N; Sánchez M; Dall'Anese C; Valderrábano F
    Nephrol Dial Transplant; 2001; 16 Suppl 1():78-81. PubMed ID: 11369828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning.
    Smith DH; Neutel JM; Weber MA
    Am J Hypertens; 2001 Jan; 14(1):14-9. PubMed ID: 11206672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
    Kirchengast M
    J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sustained release verapamil in essential hypertension].
    Yodfat Y; Nusbaum M; Gibor Y
    Harefuah; 1991 May; 120(10):581-4. PubMed ID: 1937192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension.
    Wustmann K; Kucera JP; Scheffers I; Mohaupt M; Kroon AA; de Leeuw PW; Schmidli J; Allemann Y; Delacrétaz E
    Hypertension; 2009 Sep; 54(3):530-6. PubMed ID: 19620513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood pressure responses after carotid surgery: relationship to postoperative baroreceptor sensitivity.
    Hirschl M; Kundi M; Hirschl MM; Liebisch B; Magometschnigg D
    Am J Med; 1993 May; 94(5):463-468. PubMed ID: 8498390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of antihypertensive therapy on left ventricular mass in elderly patients.
    Schulman SP; Weiss JL; Becker LC; Gottlieb SO; Woodruff KM; Weisfeldt ML; Gerstenblith G
    N Engl J Med; 1990 May; 322(19):1350-6. PubMed ID: 2139175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative study of the antihypertensive effect of verapamil and atenolol.
    Escudero J; Hernandez H; Martinez F
    Am J Cardiol; 1986 Feb; 57(7):54D-58D. PubMed ID: 3513515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
    White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
    Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does verapamil have a clinically significant antihypertensive effect?
    Pedersen OL
    Eur J Clin Pharmacol; 1978 Mar; 13(1):21-4. PubMed ID: 346353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salt sensitivity and the blood pressure response to verapamil.
    Weinberger MH; Wagner UL; Fineberg NS
    Am J Hypertens; 1994 Jun; 7(6):515-9. PubMed ID: 7917149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time course of cardiac performance in hypertensive patients after verapamil assessed by nuclear ventriculography.
    González-Gómez A; Fránquiz J; García-Barreto D
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):292-7. PubMed ID: 2387652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of verapamil in arterial hypertension].
    Carrasco RM; Luna RL; Rocha MC
    Arq Bras Cardiol; 1979 Mar; 32(3):207-11. PubMed ID: 475607
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacokinetics of verapamil: experience with a sustained intravenous infusion regimen.
    Reiter MJ; Shand DG; Aanonsen LM; Wagoner R; McCarthy E; Pritchett EL
    Am J Cardiol; 1982 Oct; 50(4):716-21. PubMed ID: 7124631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of efficacy of high-dose verapamil in preventing brain damage in baboons and pigs after prolonged partial cerebral ischemia.
    Lanza RP; Cooper DK; Barnard CN
    Am J Emerg Med; 1984 Nov; 2(6):481-5. PubMed ID: 6529457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using trade names: a risk factor for accidental drug overdose.
    Schwab M; Oetzel C; Mörike K; Jägle C; Gleiter CH; Eichelbaum M
    Arch Intern Med; 2002 May; 162(9):1065-6. PubMed ID: 11996619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.